Suvorexant

• Catalog Number: orb146219
• Category: Small Molecules
• Description: Suvorexant (MK-4305) is a potent, selective, and orally bioavailable antagonist of OX1R and OX2R currently under clinical investigation as a novel therapy for insomnia.Suvorexant is an analytical reference standard categorized as a diazepane sedative.Formulations containing suvorexant show abuse potential similar to zolpidem in recreational polydrug users with a history of sedative and psychedelic drug use.2 Suvorexant is regulated as a Schedule IV compound in the United States. This product is intended for use in analytical forensic applications.
• CAS Number: 1030377-33-3
• MW: 450.9207
• SMILES: ClC1C([H])=C([H])C2=C(C=1[H])N=C(N1C([H])([H])C([H])([H])N(C(C3C([H])=C(C([H])([H])[H])C([H])=C([H])C=3N3N=C([H])C([H])=N3)=O)[C@]([H])(C([H])([H])[H])C([H])([H])C1([H])[H])O2
• Formula: C₂₃H₂₃CLN₆O₂
• Storage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
• Alternative names: (R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Chemical structure of Suvorexant (MK-4305).